CONTRACEPTION IN DIABETIC WOMEN

Contraceptive prescription in diabetic women with current diabetic mel litus (type I or type II) or in prediabetic women with previous gestat ional diabetes mellitus must consider the specific metabolic effects a nd risks in diabetic women. This article addresses these issues, enabl ing the practitioner to develop individually tailored contraceptive pr ograms to meet the changing needs and demands of the reproductive-aged diabetic woman. It focuses on the most efficacious, reversible option available-hormonal methods and intrauterine device-both of which have been controversial for diabetic women.